Clinical Trials Logo
  1. Home
  2. Preeclampsia
  3. NCT01388283
  4. Details
NCT01388283 Clinical Trial

Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

Preeclampsia Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01388283
Other study ID # INMARPE11
Secondary ID
Status Completed
Phase N/A
First received June 30, 2011
Last updated July 5, 2011
Start date January 1999
Est. completion date June 2011

Study information
Verified date June 2011
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway:The Data InspectorateNorway: Directorate of Health
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.

Recruitment information / eligibility
Status Completed
Enrollment 129
Est. completion date June 2011
Est. primary completion date May 2004
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 43 Years
Eligibility Inclusion Criteria:

- caucasian,

- nulliparous

Exclusion Criteria:

- preexisting cardiovascular diseases,

- diabetes,

- hypertension,

- inflammatory bowel diseases,

- serious organ diseases, and

- development of separate gestational diabetes and/or hypertension.

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Oslo University Hospital
See also
  Status Clinical Trial Phase
Completed NCT03510286 - Validation of a PrCr Dipstick Diagnostic Test in Ghana
Recruiting NCT03313024 - Berlin-Brandenburg Pregnancy Cohort
Active, not recruiting NCT04990141 - Molecular Screening Method for Preeclampsia (PREMOM)
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT05999851 - Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy N/A
Recruiting NCT02923206 - Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis N/A
Terminated NCT02558023 - The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine Phase 3
Not yet recruiting NCT02541110 - Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler N/A
Completed NCT02554604 - Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
Completed NCT02854501 - Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
Completed NCT02384226 - User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
Withdrawn NCT05016440 - Lisinopril for Renal Protection in Postpartum Preeclamptic Women N/A
Recruiting NCT02337049 - Preeclampsia Subtypes and Surrogate Markers of CVD Risk N/A
Recruiting NCT02247297 - Pancreatic Stone Protein (PSP) in Pregnant Women
Completed NCT02238704 - Cornell University-Micronutrient Initiative Calcium Supplementation Study N/A
Withdrawn NCT01179542 - The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR N/A
Completed NCT01195441 - Prediction and Prevention of Preeclampsia by First Trimester Ultrasound N/A
Completed NCT00456118 - Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
Recruiting NCT00117546 - Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Phase 4
Completed NCT00787241 - Platelet Count Trends in Pre-eclamptic Parturients N/A